Surgery drug showdown: which one boosts cancer Patients' immune systems?
NCT ID NCT07432399
Summary
This study is testing which of two common drugs works better to support the body's defenses and recovery after colon cancer surgery. One hundred patients will be randomly assigned to receive either an infusion of lidocaine or a high dose of dexamethasone during their operation. Researchers will measure immune system markers and track recovery to see if one drug leads to fewer complications and a smoother healing process.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Oncology Ljubljana
RECRUITINGLjubljana, 1000, Slovenia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.